Analysts Maintain Cautious Optimism for Colgate-Palmolive Despite Market Underperformance
While Colgate-Palmolive's stock has trailed the S&P 500 over the past year, Wall Street analysts see a resilient business model and strong international presence supporting long-term growth, maintaining a 'Moderate Buy' consensus.